Automated description from the Alliance of Genome Resources
Predicted to have N,N-dimethylaniline monooxygenase activity; NADP binding activity; and amino acid binding activity. Predicted to be involved in drug metabolic process. Predicted to localize to the intracellular membrane-bounded organelle. Human ortholog(s) of this gene implicated in hypertension; inherited metabolic disorder; and trimethylaminuria. Is expressed in central nervous system and retina. Orthologous to human FMO3 (flavin containing dimethylaniline monoxygenase 3).